Keith J Kendall - Net Worth and Insider Trading
Keith J Kendall Net Worth
The estimated net worth of Keith J Kendall is at least $3 Million dollars as of 2024-09-24. Keith J Kendall is the CEO and President of Aquestive Therapeutics Inc and owns about 638,964 shares of Aquestive Therapeutics Inc (AQST) stock worth over $3 Million. Details can be seen in Keith J Kendall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith J Kendall has not made any transactions after 2020-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Keith J Kendall
Keith J Kendall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith J Kendall owns 2 companies in total, including Aquestive Therapeutics Inc (AQST) , and Femasys Inc (FEMY) .
Click here to see the complete history of Keith J Kendall’s form 4 insider trades.
Insider Ownership Summary of Keith J Kendall
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AQST | Aquestive Therapeutics Inc | 2020-06-04 | director & President and CEO |
FEMY | Femasys Inc | 2023-06-14 | director |
Keith J Kendall Latest Holdings Summary
Keith J Kendall currently owns a total of 1 stock. Keith J Kendall owns 638,964 shares of Aquestive Therapeutics Inc (AQST) as of June 4, 2020, with a value of $3 Million.
Latest Holdings of Keith J Kendall
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AQST | Aquestive Therapeutics Inc | 2020-06-04 | 638,964 | 4.88 | 3,118,144 |
Holding Weightings of Keith J Kendall
Keith J Kendall Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith J Kendall has made a total of 1 transactions in Aquestive Therapeutics Inc (AQST) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aquestive Therapeutics Inc is the sale of 50,000 shares on June 4, 2020, which brought Keith J Kendall around $255,500.
Insider Trading History of Keith J Kendall
- 1
Keith J Kendall Trading Performance
GuruFocus tracks the stock performance after each of Keith J Kendall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Keith J Kendall is 7.94%. GuruFocus also compares Keith J Kendall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith J Kendall within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Keith J Kendall's insider trading performs compared to the benchmark.
Performance of Keith J Kendall
Keith J Kendall Ownership Network
Keith J Kendall Owned Company Details
What does Aquestive Therapeutics Inc do?
Who are the key executives at Aquestive Therapeutics Inc?
Keith J Kendall is the director & President and CEO of Aquestive Therapeutics Inc. Other key executives at Aquestive Therapeutics Inc include director & Chief Innovation/Tech Officer Alexander Mark Schobel , Chief Medical Officer Carl N Kraus , and SVP & Research & Development Stephen Wargacki .
Aquestive Therapeutics Inc (AQST) Insider Trades Summary
Over the past 18 months, Keith J Kendall made no insider transaction in Aquestive Therapeutics Inc (AQST). Other recent insider transactions involving Aquestive Therapeutics Inc (AQST) include a net sale of 75,000 shares made by Alexander Mark Schobel ,
In summary, during the past 3 months, insiders sold 0 shares of Aquestive Therapeutics Inc (AQST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 75,000 shares of Aquestive Therapeutics Inc (AQST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 75,000 shares.
Aquestive Therapeutics Inc (AQST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aquestive Therapeutics Inc Insider Transactions
Keith J Kendall Mailing Address
Above is the net worth, insider trading, and ownership report for Keith J Kendall. You might contact Keith J Kendall via mailing address: 30 Technology Drive, Warren Nj 07059.